+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Nutrition Market - Global Outlook and Forecast 2021-2026

  • PDF Icon


  • 348 Pages
  • July 2021
  • Region: Global
  • Arizton
  • ID: 5360065
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Clinical Nutrition Market Report

The clinical nutrition market is expected to grow at a CAGR of 8.96% during 2021-2026.

Clinical nutrition remains significantly important to ensure better survival outcomes for patients suffering from critical conditions arising from COVID-19. The increasing number of malnutrition cases is surging the industry growth. Clinical nutrition is a highly regulated market and is generally prescribed for intake during medical supervision across various settings such as hospitals, clinics, and home care facilities.

The following factors are likely to contribute to the growth of the clinical nutrition market during the forecast period:
  • Rising Incidence of Chronic and Metabolic Disorders
  • Increasing Preference of Enteral Over Parenteral
  • High Demand for Clinical Nutrition Among Cancer Patients
  • Growing Popularity of Home-Based Healthcare

The report considers the present scenario of the clinical nutrition market and its market dynamics for the period 2021-2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.


The global clinical nutrition market research report includes a detailed segmentation by route of administration, age group, product type, application, distributional channels, end-users, geography. Focusing on health and wellness, aging well, and disease prevention by consumers, healthcare providers are demanding preventive clinical nutrition products and are experiencing rapid growth. Vendors are offering the product in dessert, yogurt, soup, and savory-style and as powders to grab customers’ attention. The key players are investing in research activities to formulate a nutritional supplement that provides nutritional benefits to patients suffering from certain medical conditions.

Global brands such as Abbott, Nestle, Nutricia, and Fresenius Kabi offer parenteral, enteral, and oral nutrition products for infants. The percentage of infants suffering from lactose intolerance is incredibly high and accounts for 71% of the population. The market has also been experiencing high demand owing to the heavy ad campaigns. The increasing prevalence of malnutrition among children is primarily driving the demand for clinical nutrition among children.

Latin America and APAC are expected to witness high traction for semi-solid powder products in the industry. Most standard clinical nutrition products are powder-based as they offer 100% micro and macronutrient requirements. Players are observing the highest level of adoption of clinical nutrition in physical stores such as supermarkets, hypermarkets, and other e-commerce websites due to the flexibility offered in packaging techniques.

In recent years, the syndrome of metabolic disorders is becoming much more common in the United States. About 37% of adult Americans are estimated to have metabolic disorders thereby, surging the demand for clinical nutrition across the globe. Major innovations and advancements in the fields of nutrition have led to rapid growth in the industry over the last decade. The developing Asian countries are becoming a focal point for significant players in the market.

The distribution of clinical nutrition products is highly significant, requiring research activities to understand the most effective and safe channel. An ideal distribution mix consisting of a considerable share of each delivery mode is regarded as the most successful strategy. Major retail channels such as Walmart, Costco, Walgreens, Sainsbury’s, Morrisons serve as the primary sources of sales in the western countries.

The rising incidence of malnutrition among hospitalized patients drives the demand for oral, enteral, and parenteral nutritional products across the globe. Vendors are arranging training sessions on equipment and feed for hospital-based healthcare professionals and patients to increase the sales of clinical nutrition. Brands such as Abbott and B. Braun offering ready-to-drink nutrition products for patients suffering from chronic diseases that are easy to consume, and flavorful products are likely to gain greater consumer attention.

Segmentation by Route of Administration
  • Oral
  • Enteral
  • Parenteral

Segmentation by Age Group
  • Infant & Toddler
  • Child & Teenager
  • Adult
  • Geriatric

Segmentation by Product Type
  • Powder
  • Liquid
  • Semi-Solid

Segmentation by Application
  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Cancer
  • Others

Segmentation by Distributional Channels
  • Institutional Sales
  • Pharmacy & Drugstores
  • Supermarkets & Hypermarkets
  • Online Channels
  • Specialty Stores
  • Others

Segmentation by End-Users
  • Hospitals
  • Individuals
  • Homecare
  • LTC


The proportion of cancer deaths in Asia is about 58.3% higher than the cancer incidence rate. The prevalence of chronic diseases is increasing the demand for clinical nutrition products in the region. The rapid rise of the e-commerce industry in the Asia Pacific is likely to remain at the forefront of the rapid growth of the online sale of nutritional products in the Asia Pacific. A large base of the population and the presence of high medical needs are expected to create new growth avenues for the market in the region.

Segmentation by Geography
  • APAC
  • China
  • Japan
  • South Korea
  • Australia
  • India
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • UAE


The global clinical nutrition market is becoming highly consolidated, with a rising number of mergers and acquisitions occurring globally. Due to the possibility of incremental growth, the non-traditional players are expected to venture into the clinical nutritional supplement market during the forecast period. The global market is highly competitive with the presence of significant vendors. Abbott Laboratories, Baxter International, B. Braun, Danone, and Nestle Health Science are the major players. Due to the higher level of fragmentation, most players engage in mergers and acquisitions to overcome the competitive edge across the industry.

Key Vendors:
  • Abbott
  • Baxter
  • B. Braun
  • Danone
  • Nestle Health Science

Other Prominent Vendors:
  • Ajinomoto Cambrooke
  • American Regent
  • AnazaoHealth
  • Avadel Pharmaceutical
  • Exela Pharma Science
  • Fresenius Kabi
  • Grifols
  • ICU Medical
  • Lonzo
  • Mead Johnson & Company
  • Meiji Holdings Company
  • Otsuka Pharmaceutical Company
  • Perrigo Company
  • Reckitt Benckiser
  • Sanofi
  • Sichuan Kelun Pharmaceutical
  • Stepen Company


1. How big is the clinical nutrition market?
2. What is the U.S. clinical nutrition market growth?
3. Which segment has the highest growth rate in the global clinical nutrition market?
4. Which are the top companies holding the highest share in the market?
5. What are the key trends in the medical nutrition market report?

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of the Study
4.4 Market Segmentation
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.2 Impact of COVID-19 on the Global Clinical Nutrition Market
8 Market Opportunities & Trends
8.1 Increasing Use of Whey Protein in Clinical Nutrition
8.2 Growing Popularity of Home-Based Healthcare
8.3 Growing Demand for Parenteral Nutrition
8.4 Increased Demand in Developing Countries
9 Market Growth Enablers
9.1 High Incidence of Malnutrition Among Hospitalized Patients
9.2 Higher Nutritional Requirement Among the Geriatric Population
9.3 Rising Incidence of Chronic and Metabolic Disorders
9.4 Increasing Preference for Enteral Over Parenteral
9.5 High Demand for Clinical Nutrition Among Cancer Patients
10 Market Restraints
10.1 Complications Related to Enteral Feeding
10.2 Stringent Regulations
10.3 Irregular Reimbursement Coverage for Clinical Nutrition
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
12 Route of Administration
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
13 Oral
13.1 Market Overview
13.2 Market Size & Forecast
13.3 Infant & Toddler Oral Nutrition: Market Size & Forecast
13.4 Child & Teenager Oral Nutrition: Market Size & Forecast
13.5 Adult Oral Nutrition: Market Size & Forecast
13.6 Geriatric Oral Nutrition: Market Size & Forecast
14 Enteral
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Infant & Toddler Enteral Nutrition: Market Size & Forecast
14.4 Child & Teenager Enteral Nutrition: Market Size & Forecast
14.5 Adult Enteral Nutrition: Market Size & Forecast
14.6 Geriatric Enteral Nutrition: Market Size & Forecast
15 Parenteral
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Infant & Toddler Parenteral Nutrition: Market Size & Forecast
15.4 Child & Teenager Parenteral Nutrition: Market Size & Forecast
15.5 Adult Parenteral Nutrition: Market Size & Forecast
15.6 Geriatric Parenteral Nutrition: Market Size & Forecast
16 Age Group
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Infant & Toddler
16.4 Child & Teenager
16.5 Adult
16.6 Geriatric
17 Product Type
17.1 Market Snapshot & Growth Engine
17.2 Market Overview
17.3 Powder
17.4 Liquid
17.5 Semi-Solid
18 Application
18.1 Market Snapshot & Growth Engine
18.2 Market Overview
18.3 Malnutrition
18.4 Metabolic Disorders
18.5 Gastrointestinal Disorders
18.6 Cancer
18.7 Others
19 Distribution Channel
19.1 Market Snapshot & Growth Engine
19.2 Market Overview
19.3 Institutional Sales
19.4 Pharmacies And Drugstores
19.5 Supermarkets & Hypermarkets
19.6 Online Channels
19.7 Specialty Stores
20 End-Users
20.1 Market Snapshot & Growth Engine
20.2 Market Overview
20.3 Hospitals
20.4 Individual
20.5 Homecare
20.6 LTC
21 Geography
21.1 Market Snapshot & Growth Engine
21.2 Geographic Overview
22.1 Market Overview
22.2 Market Size & Forecast
22.3 Route of Administration
22.4 Product Type
22.5 Age Group
22.6 Application
22.7 Distribution Channels
22.8 End-Users
22.9 Key Countries
23 North America
23.1 Market Overview
23.2 Market Size & Forecast
23.3 Route of Administration
23.4 Product Type
23.5 Age Group
23.6 Application
23.7 Distribution Channels
23.8 End-Users
23.9 Key Countries
24 Europe
24.1 Market Overview
24.2 Market Size & Forecast
24.3 Route of Administration
24.4 Product Type
24.5 Age Group
24.6 Application
24.7 Distribution Channels
24.8 End-Users
24.9 Key Countries
25 Latin America
25.1 Market Overview
25.2 Market Size & Forecast
25.3 Route of Administration
25.4 Product Type
25.5 Age Group
25.6 Application
25.7 Distribution Channels
25.8 End-Users
25.9 Key Countries
26 Middle East & Africa
26.1 Market Overview
26.2 Market Size & Forecast
26.3 Route of Administration
26.4 Product Type
26.5 Age Group
26.6 Application
26.7 Distribution Channels
26.8 End-Users
26.9 Key Countries
27 Competitive Landscape
27.1 Competition Overview
28 Key Company Profiles
28.1 Abbott
28.2 Baxter
28.3 B. Braun
28.4 Danone
28.5 Nestle Health Science
29 Other Prominent Vendors
29.1 Ajinomoto Cambrooke
29.2 American Regent
29.3 AnazaoHealth
29.4 Avadel
29.5 BASF SE
29.6 Exela Pharma Sciences
29.7 Fresenius Kabi
29.8 Grifols
29.9 ICU Medical
29.10 Lonza
29.11 Mead Johnson & Company
29.12 Meiji Holdings Company
29.13 Otsuka Pharmaceutical Company
29.14 Perrigo Company
29.15 Reckitt Benckiser
29.16 Sanofi
29.17 Sichuan Kelun Pharmaceutical
29.18 Stepan Company
30 Report Summary
30.1 Key Takeaways
30.2 Strategic Recommendations
31 Quantitative Summary
31.1 Route of Administration
31.2 Product Type
31.3 Age Group
31.4 Application
31.5 Distribution Channels
31.6 End-Users
31.7 Market by Geography
31.8 APAC
31.9 North America
31.10 Europe
31.11 Latin America
31.12 Middle East & Africa
32 Appendix
32.1 Abbreviations

Companies Mentioned

  • Abbott
  • Baxter
  • B. Braun
  • Danone
  • Nestle Health Science
  • Ajinomoto Cambrooke
  • American Regent
  • AnazaoHealth
  • Avadel Pharmaceutical
  • Exela Pharma Science
  • Fresenius Kabi
  • Grifols
  • ICU Medical
  • Lonzo
  • Mead Johnson & Company
  • Meiji Holdings Company
  • Otsuka Pharmaceutical Company
  • Perrigo Company
  • Reckitt Benckiser
  • Sanofi
  • Sichuan Kelun Pharmaceutical
  • Stepen Company


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



Table Information